Vaccines List

M-001 Influenza Vaccine

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

M-M-R II Vaccine

M-M-R II vaccine is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus MMR vaccine.Read more...

M72/AS01E Tuberculosis Vaccine

M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the adjuvant AS01E.Read more...

Measles Vaccines

Measles is a highly infectious virus that can be prevented by the MMR vaccine.Read more...

Medigen COVID-19 Vaccine

Medigen MVC-COV1901 COVID-19 Vaccine is adjuvanted with Dynavax CpG 1018.Read more...

MenABCWY Meningococcal (PF-06886992) Vaccine

Pfizer’s pentavalent meningococcal vaccine candidate (PF-06886992) combines its two approved meningococcal vaccines, Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).Read more...

Menactra Meningococcal Vaccine

Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein.Read more...

Meningococcal Vaccines

Meningococcal vaccines prevent illnesses caused by bacteria called Neisseria meningitidis.Read more...

Menveo Meningococcal Vaccine

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...

MK-7110 COVID-19 Therapeutic

MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system.Read more...

Mosquirix RTSS/AS01 Malaria Vaccine

Mosquirix (RTS,S/AS01) (RTS,S) is a recombinant malaria vaccine.Read more...

mRNA-1010 Quadrivalent Influenza Vaccine

Moderna mRNA-1010 Quadrivalent Influenza Vaccine candidate targets the WHO flu lineages recommendationsRead more...

mRNA-1189 Epstein-Barr Virus Vaccine

mRNA-1189 Epstein-Barr Virus vaccine candidate is being developed to prevent EBV-induced IM and potentially EBV infectionRead more...

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine candidate encodes for a prefusion F glycoprotein, which elicits a superior neutralizing antibody response.Read more...

mRNA-1574 HIV Vaccine

Moderna mRNA-1574 mRNA-1644 are HIV Vaccine candidates that utilize multiple mRNAs encoded native-like HIV trimers.Read more...

mRNA-1608 Herpes Vaccine

Moderna mRNA-1608 herpes mRNA vaccine candidate is targeted against HSV-2 that could provide cross-protection against HSV-1.Read more...

mRNA-1647 Cytomegalovirus Vaccine

Moderna Inc. mRNA-1647 is designed to produce an immune response to both pentamer and gB antigens to prevent CMV infection.Read more...

mRNA-1653 hMPV+PIV3 Vaccine

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

mRNA-1893 Zika Vaccine

Moderna mRNA-1893 vaccine contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles.Read more...

mRNA-1944 Chikungunya Vaccine

Moderna's mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

mRNA-4157 Cancer Vaccine

Moderna's mRNA-4157 is a therapeutic cancer vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes, and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...

MRT5400/MRT5401 mRNA Influenza Vaccine

Sanofi's MRT5400 and MRT5401 are mRNA Influenza Vaccine candidates that are entering a phase 1 clinical trial.Read more...

MRT5500 mRNA Vaccine

Translate Bio and Sanofi MRT5500 is an mRNA SARS-CoV-2 vaccine candidateRead more...

MTBVAC Tuberculosis Vaccine

MTBVAC Tuberculosis Vaccine is a live attenuated vaccine candidate against Mycobacterium tuberculosis.Read more...

MV-CHIK Chikungunya Vaccine

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

MV-LASV Lassa Fever Vaccine

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVA MERS-S Vaccine

MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...

MVA-BN RSV Vaccine

MVA-BN RSV vaccine incorporates five different RSV antigens to stimulate a broad immune responseRead more...

MVA-M1+NP Influenza A Vaccine

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

MVX-ONCO-1 Cancer Immunotherapy Vaccine

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...